- Home
- Health Topics
- Articles
- Video
Methylin is a medication that is approved to treat narcolepsy in adults and ADHD in children. This segment of the eMedTV archives explains how the drug works and further explores its effects, potential side effects, and dosage information.
Dizziness, insomnia, and nausea are among the most common side effects seen with Methylin. This eMedTV page also lists rare Methylin side effects, problems that may require medical attention, and other common side effects of the drug.
In clinical studies, weight loss was a commonly reported side effect of Methylin. This eMedTV segment discusses Methylin and weight loss in more detail and explains how the medication is also occasionally used as a short-term weight loss treatment.
Depression is a potential side effect of Methylin, but its frequency is unknown. This eMedTV page discusses Methylin and depression in detail, including an explanation of how clinical trials work and how the drug can also be used to treat depression.
Studies are currently being conducted on the long-term side effects of Methylin. This eMedTV segment discusses the research findings on long-term use of the drug, which may include growth suppression and changes in brain chemistry.
Methylin is primarily used for the treatment of ADHD and narcolepsy. This page on the eMedTV site discusses specific Methylin uses in detail, explains how it can be used in children as young as six, and lists possible off-label uses for the drug.
Most children start with a Methylin dosage of 5 mg, taken twice a day. This section of the eMedTV library also offers dosage recommendations for adults and provides tips, precautions, and general guidelines for people taking the medication.
Drugs that may potentially cause Methylin interactions include pressors, warfarin, and MAOIs. This eMedTV resource lists other medicines that may cause negative interactions when taking with Methylin and describes the possible effects.
This eMedTV article lists Methylin warnings and precautions, including conditions you should tell your doctor about and people who should not take the drug. For example, people who have used an MAOI within the past two weeks should not take it.
This eMedTV segment discusses the risks when combining Methylin and pregnancy, and describes when a healthcare provider may prescribe the drug to a pregnant woman. An explanation of the FDA's system of rating drugs during pregnancy is also provided.
Hallucinations, confusion, and seizures are possible signs of a Methylin overdose. This eMedTV Web page lists other potential overdose symptoms and describes the different treatment options that are available for people who take too much Methylin.
There are currently no generic Methylin products available. As this eMedTV article explains, while the patents for Methylin Chewable Tablets and Methylin Oral Solution have expired, generic forms of the drugs have not been manufactured.
Methylin, a controlled substance, can be habit-forming and easily abused. As this page of the eMedTV site explains, because Methylin and other Class 2 controlled substances have the potential for abuse, there are special rules for prescribing them.
Methylin abuse is common, given the habit-forming nature of the drug. This eMedTV resource lists common reasons for this abuse, explains the dangers of Methylin addiction and abuse, and offers information on where you can get help.
Children with ADHD often benefit from using Methylin. Adults may also use it as an off-label ADHD medicine. This eMedTV article discusses Methylin use in adults and offers important precautions for adults who are taking the medication.
There are many alternatives to Methylin, including other medications and lifestyle changes. This eMedTV page describes lifestyle changes that are important to an ADHD treatment program and lists medications that can be used instead of Methylin.
| Referring Pages | Articles |
